Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04478279
Title A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sapience Therapeutics
Indications

progesterone-receptor positive breast cancer

carcinoma

melanoma

estrogen-receptor positive breast cancer

glioblastoma

sarcoma

prostate cancer

Therapies

ST-101

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California, San Francisco Recruiting San Francisco California 94143 United States Details
Sarah Cannon Research Institute Recruiting Denver Colorado 80218 United States Details
Northwestern Medicine Cancer Centers Recruiting Warrenville Illinois 60555 United States Details
START Midwest Recruiting Grand Rapids Michigan 49503 United States Details
Columbia University Recruiting New York New York 10032 United States Details
Duke University School of Medicine Recruiting Durham North Carolina 27708 United States Details
Sarah Cannon Research Institute Recruiting Nashville Tennessee 37203 United States Details
Texas Oncology - Baylor Charles A. Sammons Cancer Center Recruiting Dallas Texas 75246 United States Details
Edinburgh Cancer Centre Recruiting Edinburgh EH4 2SP United Kingdom Details
The Beaston West of Scotland Cancer Centre Recruiting Glasgow G12 0YN United Kingdom Details
University of Leeds Recruiting Leeds LS9 7TF United Kingdom Details
Sarah Cannon Research Institute UK Recruiting London W1G 6AD United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field